-
Cancer Care Does Not Move in Straight Lines
Cathy Nobil-Dutton did all the right things to protect her health, but a uterine cancer diagnosis showed her life doesn’t always go as expected.
by Cathy Nobil-Dutton
-
Regular Aspirin Use May Help Fight Colorectal Cancer
Aspirin appears to activate an immune response against colorectal cancer in the early stages of the disease.
by Sandra Gordon
-
Progress Against Cancer
New research fuels progress in cancer survival, prevention and side effect management.
-
Experts Urge Consideration Before Switching Cancer Care Providers
Patients should consider the potential risks, and not just rewards, before changing providers.
by Kyle Bagenstose
-
Vaccines Spark Activity in Pancreatic Cancer
Scientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.
by Thomas Celona
-
Navigating Out of Financial Toxicity
People with cancer face an increased risk of financial hardship. Education and expert guidance can offer patients a lifeline.
by Thomas Celona
-
Taking Answers Home
Advocates bring the patient perspective to the AACR Annual Meeting 2024 and leave with tools to better communicate advances in care to others.
by Eric Fitzsimmons
-
Lifestyle Choices and Cancer
What people eat and drink and their level of physical activity can affect their risk of having cancer. New interventions aim to reduce risk factors.
by Kevin McLaughlin
-
Forward Look
Improving Colorectal Cancer Screening OptionsTests currently in development seek to offer greater accuracy and reach more people.
by Eric Fitzsimmons
-
Endometrial Cancer and Screening for Lynch Syndrome
AACR highlights team research that led to Lynch syndrome testing for all people with endometrial cancer in the U.K.
by Marci A. Landsmann
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles